| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |